By Manas Mishra (Reuters) -Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug ...

An exclusive report by The Wall Street Journal details how Microsoft unveiled OpenAI's unreleased GPT-4 to the world without ...

Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...

Commissioner Marty Makary signed off on the plan to push out the agency’s top vaccine official, Peter Marks, in one of his ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Ouster is a high-growth LiDAR technology company with a strong balance sheet, but breakeven is still several years away. Read ...

The Town of Tonawanda has formally accused members of its police force of violating the state's Taylor Law by participating ...

Ouster's growth potential, competitive edge, and strong financial outlook make it a top buy, with a $27 target. Learn why ...

After the ouster of Bangladesh Prime Minister Sheikh Hasina, religious fundamentalists in one town announced that young women ...

Tesla CEO Elon Musk reportedly plans to step back from his role in Trump administration. But the DOGE head has denied the ...

Democrats are calling for Defense Secretary Pete Hegseth and national security adviser Michael Waltz to step down ...